{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:32:46Z","timestamp":1784734366006,"version":"3.55.0"},"reference-count":43,"publisher":"The Endocrine Society","issue":"10","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK075084-08"],"award-info":[{"award-number":["DK075084-08"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["ZIA DK071013"],"award-info":[{"award-number":["ZIA DK071013"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Leptin is an adipokine that signals energy sufficiency. In rodents, leptin deficiency decreases energy expenditure (EE), which is corrected following leptin replacement. In humans, data are mixed regarding leptin-mediated effects on EE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To determine the effects of metreleptin on EE in patients with lipodystrophy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design, setting, and patients<\/jats:title>\n                  <jats:p>Nonrandomized crossover study of 25 patients with lipodystrophy (National Institutes of Health, 2013-2018).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Intervention<\/jats:title>\n                  <jats:p>The initiation cohort consisted of 17 patients without prior exposure to metreleptin, studied before and after 14 days of metreleptin. The withdrawal cohort consisted of 8 previously metreleptin-treated patients, studied before and after 14 days of metreleptin withdrawal.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcomes<\/jats:title>\n                  <jats:p>24-h total energy expenditure (TEE), resting energy expenditure (REE), autonomic nervous system activity [heart rate variability (HrV)], plasma-free triiodothyronine (T3), free thyroxine (T4), epinephrine, norepinephrine, and dopamine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the initiation cohort, TEE and REE decreased by 5.0% (121\u2005\u00b1\u2005152 kcal\/day; P\u2005=\u20050.006) and 5.9% (120\u2005\u00b1\u2005175 kcal\/day; P\u2005=\u20050.02). Free T3 increased by 19.4% (40\u2005\u00b1\u200549 pg\/dL; P\u2005=\u20050.01). No changes in catecholamines or HrV were observed. In the withdrawal cohort, free T3 decreased by 8.0% (P\u2005=\u20050.04), free T4 decreased by 11.9% (P\u2005=\u20050.002), and norepinephrine decreased by 34.2% (P\u2005=\u20050.03), but no changes in EE, epinephrine, dopamine, or HrV were observed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Metreleptin initiation decreased EE in patients with lipodystrophy, but no changes were observed after metreleptin withdrawal. Thyroid hormone was higher on metreleptin in both initiation and withdrawal cohorts. Decreased EE after metreleptin in lipodystrophy may result from reductions in energy-requiring metabolic processes that counteract increases in EE via adipose tissue-specific neuroendocrine and adrenergic signaling.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgab269","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T08:20:39Z","timestamp":1619166039000},"page":"e4163-e4178","source":"Crossref","is-referenced-by-count":19,"title":["Leptin Decreases Energy Expenditure Despite Increased Thyroid Hormone in Patients With Lipodystrophy"],"prefix":"10.1210","volume":"106","author":[{"given":"Andrew","family":"Grover","sequence":"first","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Quaye","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Brychta","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Christensen","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan S","family":"Startzell","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Adelia","family":"Meehan","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areli","family":"Valencia","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Marshall","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kong Y","family":"Chen","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2589-7382","authenticated-orcid":false,"given":"Rebecca J","family":"Brown","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"issue":"6704","key":"2021110611592955400_CIT0001","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature."},{"issue":"5223","key":"2021110611592955400_CIT0002","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.7624776","article-title":"Effects of the obese gene product on body weight regulation in ob\/ob mice","volume":"269","author":"Pelleymounter","year":"1995","journal-title":"Science."},{"issue":"6","key":"2021110611592955400_CIT0003","doi-asserted-by":"crossref","first-page":"R938","DOI":"10.1152\/ajpregu.00045.2016","article-title":"Role of leptin in energy expenditure: the hypothalamic perspective","volume":"312","author":"Pandit","year":"2017","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"issue":"6636","key":"2021110611592955400_CIT0004","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/43185","article-title":"Congenital leptin deficiency is associated with severe early-onset obesity in humans","volume":"387","author":"Montague","year":"1997","journal-title":"Nature."},{"issue":"9","key":"2021110611592955400_CIT0005","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1172\/JCI200317490","article-title":"The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men","volume":"111","author":"Chan","year":"2003","journal-title":"J Clin Invest."},{"issue":"5","key":"2021110611592955400_CIT0006","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1210\/jcem.87.5.8628","article-title":"Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones","volume":"87","author":"Rosenbaum","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2021110611592955400_CIT0007","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1172\/JCI25977","article-title":"Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight","volume":"115","author":"Rosenbaum","year":"2005","journal-title":"J Clin Invest."},{"issue":"5","key":"2021110611592955400_CIT0008","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2014-4491","article-title":"Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin","volume":"100","author":"Diker-Cohen","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021110611592955400_CIT0009","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jhep.2013.02.007","article-title":"The liver diseases of lipodystrophy: the long-term effect of leptin treatment","volume":"59","author":"Safar Zadeh","year":"2013","journal-title":"J Hepatol."},{"issue":"4","key":"2021110611592955400_CIT0010","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.metabol.2003.10.019","article-title":"Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy","volume":"53","author":"Moran","year":"2004","journal-title":"Metabolism."},{"issue":"10","key":"2021110611592955400_CIT0011","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy","volume":"109","author":"Petersen","year":"2002","journal-title":"J Clin Invest."},{"issue":"8","key":"2021110611592955400_CIT0012","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1172\/JCI95476","article-title":"Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy","volume":"128","author":"Brown","year":"2018","journal-title":"J Clin Invest."},{"issue":"2","key":"2021110611592955400_CIT0013","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1079\/BJN19700050","article-title":"Calorie conversion factors. An experimental reassessment of the factors used in the calculation of the energy value of human diets","volume":"24","author":"Southgate","year":"1970","journal-title":"Br J Nutr."},{"issue":"6","key":"2021110611592955400_CIT0014","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1172\/JCI112749","article-title":"Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber","volume":"78","author":"Ravussin","year":"1986","journal-title":"J Clin Invest."},{"issue":"3","key":"2021110611592955400_CIT0015","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/ajcn\/40.3.542","article-title":"Diet-induced thermogenesis measured over a whole day in obese and nonobese women","volume":"40","author":"Schutz","year":"1984","journal-title":"Am J Clin Nutr."},{"issue":"1","key":"2021110611592955400_CIT0016","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1152\/ajpregu.00474.2002","article-title":"Effects of experimental weight perturbation on skeletal muscle work efficiency in human subjects","volume":"285","author":"Rosenbaum","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"2021110611592955400_CIT0017","article-title":"Ergonomics\u2014Evaluation of Thermal Strain by Physiological Measurements","author":"International Organization for Standardization","year":"2004"},{"key":"2021110611592955400_CIT0018","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1152\/jappl.1964.19.3.531","article-title":"A new weighting system for mean surface temperature of the human body","volume":"19","author":"Ramanathan","year":"1964","journal-title":"J Appl Physiol."},{"issue":"6 Pt 2","key":"2021110611592955400_CIT0019","first-page":"R1418","article-title":"Heart rate variability as a measure of autonomic function during weight change in humans","volume":"261","author":"Hirsch","year":"1991","journal-title":"Am J Physiol."},{"issue":"2","key":"2021110611592955400_CIT0020","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2006-1546","article-title":"Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy","volume":"92","author":"Ebihara","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021110611592955400_CIT0021","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.metabol.2004.08.021","article-title":"The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients","volume":"54","author":"Musso","year":"2005","journal-title":"Metabolism."},{"issue":"5","key":"2021110611592955400_CIT0022","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.tem.2015.03.003","article-title":"Physiology and relevance of human adaptive thermogenesis response","volume":"26","author":"Celi","year":"2015","journal-title":"Trends Endocrinol Metab."},{"issue":"1","key":"2021110611592955400_CIT0023","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1038\/s41467-020-18885-9","article-title":"Leptin alters energy intake and fat mass but not energy expenditure in lean subjects","volume":"11","author":"Chrysafi","year":"2020","journal-title":"Nat Commun."},{"issue":"6","key":"2021110611592955400_CIT0024","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00075197-200411000-00007","article-title":"Leptin and energy expenditure","volume":"7","author":"Hukshorn","year":"2004","journal-title":"Curr Opin Clin Nutr Metab Care."},{"issue":"4","key":"2021110611592955400_CIT0025","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/ajcn\/77.4.771","article-title":"Pegylated human recombinant leptin (PEG-OB) causes additional weight loss in severely energy-restricted, overweight men","volume":"77","author":"Hukshorn","year":"2003","journal-title":"Am J Clin Nutr."},{"issue":"16","key":"2021110611592955400_CIT0026","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1073\/pnas.1015674108","article-title":"Leptin is an effective treatment for hypothalamic amenorrhea","volume":"108","author":"Chou","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"8","key":"2021110611592955400_CIT0027","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI0215693","article-title":"Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency","volume":"110","author":"Farooqi","year":"2002","journal-title":"J Clin Invest."},{"issue":"11","key":"2021110611592955400_CIT0028","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1210\/jcem.85.11.6955","article-title":"Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men","volume":"85","author":"Hukshorn","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021110611592955400_CIT0029","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/ajcn\/74.4.426","article-title":"Effects of weekly administration of pegylated recombinant human OB protein on appetite profile and energy metabolism in obese men","volume":"74","author":"Westerterp-Plantenga","year":"2001","journal-title":"Am J Clin Nutr."},{"issue":"14","key":"2021110611592955400_CIT0030","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137180","article-title":"Leptin decreases de novo lipogenesis in patients with lipodystrophy","volume":"5","author":"Baykal","year":"2020","journal-title":"JCI Insight"},{"issue":"7","key":"2021110611592955400_CIT0031","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1172\/JCI135431","article-title":"Free fatty acid processing diverges in human pathologic insulin resistance conditions","volume":"130","author":"Sekizkardes","year":"2020","journal-title":"J Clin Invest."},{"issue":"1","key":"2021110611592955400_CIT0032","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1210\/endo.140.1.6399","article-title":"Induction of uncoupling protein expression in brown and white adipose tissue by leptin","volume":"140","author":"Commins","year":"1999","journal-title":"Endocrinology"},{"issue":"2","key":"2021110611592955400_CIT0033","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1152\/physrev.00030.2013","article-title":"Thyroid hormone regulation of metabolism","volume":"94","author":"Mullur","year":"2014","journal-title":"Physiol Rev."},{"issue":"4","key":"2021110611592955400_CIT0034","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1159\/000501319","article-title":"Leptin is not essential for obesity-associated hypertension","volume":"12","author":"von Schnurbein","year":"2019","journal-title":"Obes Facts."},{"issue":"25","key":"2021110611592955400_CIT0035","doi-asserted-by":"crossref","first-page":"14623","DOI":"10.1073\/pnas.96.25.14623","article-title":"Torpor in mice is induced by both leptin-dependent and -independent mechanisms","volume":"96","author":"Gavrilova","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"2021110611592955400_CIT0036","doi-asserted-by":"crossref","first-page":"e0189784","DOI":"10.1371\/journal.pone.0189784","article-title":"Energy homeostasis in leptin deficient Lepob\/ob mice","volume":"12","author":"Skowronski","year":"2017","journal-title":"Plos One."},{"issue":"9","key":"2021110611592955400_CIT0037","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.2337\/diabetes.48.9.1787","article-title":"Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion","volume":"48","author":"Satoh","year":"1999","journal-title":"Diabetes."},{"issue":"8","key":"2021110611592955400_CIT0038","first-page":"597","article-title":"Diminished epinephrine excretion in genetically obese (ob\/ob) mice and monosodium glutamate-treated rats","volume":"16","author":"Leigh","year":"1992","journal-title":"Int J Obes Relat Metab Disord."},{"issue":"8","key":"2021110611592955400_CIT0039","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s42255-019-0099-7","article-title":"Hypothalamic dopamine signaling regulates brown fat thermogenesis","volume":"1","author":"Folgueira","year":"2019","journal-title":"Nat Metab."},{"issue":"3","key":"2021110611592955400_CIT0040","first-page":"243","article-title":"Association between heart rate variability and manual pulse rate","volume":"57","author":"Hart","year":"2013","journal-title":"J Can Chiropr Assoc."},{"issue":"1","key":"2021110611592955400_CIT0041","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/oby.2003.2","article-title":"Measuring activity of the autonomic nervous system in humans","volume":"11","author":"Hirsch","year":"2003","journal-title":"Obes Res."},{"issue":"2","key":"2021110611592955400_CIT0042","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1210\/jc.2009-1739","article-title":"Leptin replacement prevents weight loss-induced metabolic adaptation in congenital leptin-deficient patients","volume":"95","author":"Galgani","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2021110611592955400_CIT0043","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa040388","article-title":"Recombinant human leptin in women with hypothalamic amenorrhea","volume":"351","author":"Welt","year":"2004","journal-title":"N Engl J Med."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab269\/39812077\/dgab269.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/10\/e4163\/41098121\/dgab269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/10\/e4163\/41098121\/dgab269.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T12:01:13Z","timestamp":1636200073000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/10\/e4163\/6247344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,4,23]]},"published-print":{"date-parts":[[2021,9,27]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab269","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,4,23]]}}}